Paper32010293
Human cardiac extracellular matrix-chitosan-gelatin composite scaffold and its endothelialization.
Lv J and 6 others. Exp Ther Med, 2020. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Human cardiac extracellular matrix-chitosan-gelatin composite scaffold and its endothelialization. Papers, record 32010293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32010293
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human cardiac extracellular matrix-chitosan-gelatin composite scaffold and its endothelialization.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29,770,300 | Tissue engineered vascular grafts for pediatric cardiac surgery. | Transl Pediatr | 2018 | https://conductscience.org/library/papers/29770300 | PubMed |
| 2 | 29,078,233 | Comparing the Host Reaction to CorMatrix and Different Cardiac Patch Materials Implanted Subcutaneously in Growing Pigs. | Thorac Cardiovasc Surg | 2019 | https://conductscience.org/library/papers/29078233 | PubMed |
| 3 | 28,142,371 | Preparation and Characterization of a Chitosan/Gelatin/Extracellular Matrix Scaffold and Its Application in Tissue Engineering. | Tissue Eng Part C Methods | 2017 | https://conductscience.org/library/papers/28142371 | PubMed |
| 4 | 19,108,001 | Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access. | Br J Surg | 2009 | https://conductscience.org/library/papers/19108001 | PubMed |
| 5 | 28,714,856 | Use of human aortic extracellular matrix as a scaffold for construction of a patient-specific tissue engineered vascular patch. | Biomed Mater | 2017 | https://conductscience.org/library/papers/28714856 | PubMed |
| 6 | 30,070,814 | [Preparation and evaluation of extracellular matrix scaffold of human adipose tissue]. | Zhonghua Zheng Xing Wai Ke Za Zhi | 2017 | https://conductscience.org/library/papers/30070814 | PubMed |
| 7 | 30,639,349 | Biomimetic modification of poly(vinyl alcohol): Encouraging endothelialization and preventing thrombosis with antiplatelet monotherapy. | Acta Biomater | 2019 | https://conductscience.org/library/papers/30639349 | PubMed |
| 8 | 27,956,366 | Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction. | Acta Biomater | 2017 | https://conductscience.org/library/papers/27956366 | PubMed |
| 9 | 15,321,944 | Endothelial progenitor cells: characterization and role in vascular biology. | Circ Res | 2004 | https://conductscience.org/library/papers/15321944 | PubMed |
| 10 | 28,179,595 | Outcomes of Totally Endoscopic Atrial Septal Defect Closure Using a Glutaraldehyde-Treated Autologous Pericardial Patch. | Circ J | 2017 | https://conductscience.org/library/papers/28179595 | PubMed |
| 11 | 19,379,142 | Drug releasing systems in cardiovascular tissue engineering. | J Cell Mol Med | 2009 | https://conductscience.org/library/papers/19379142 | PubMed |
| 12 | 24,291,155 | Extracellular matrix as an inductive scaffold for functional tissue reconstruction. | Transl Res | 2014 | https://conductscience.org/library/papers/24291155 | PubMed |
| 13 | 15,912,049 | Comparison of small-intestinal submucosa and expanded polytetrafluoroethylene as a vascular conduit in the presence of gram-positive contamination. | Ann Surg | 2005 | https://conductscience.org/library/papers/15912049 | PubMed |
| 14 | 20,188,872 | The effects of pore architecture in silk fibroin scaffolds on the growth and differentiation of mesenchymal stem cells expressing BMP7. | Acta Biomater | 2010 | https://conductscience.org/library/papers/20188872 | PubMed |
| 15 | 30,386,701 | Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease. | PeerJ | 2018 | https://conductscience.org/library/papers/30386701 | PubMed |
| 16 | 27,424,216 | Three-dimensional scaffolds of fetal decellularized hearts exhibit enhanced potential to support cardiac cells in comparison to the adult. | Biomaterials | 2016 | https://conductscience.org/library/papers/27424216 | PubMed |
| 17 | 15,893,169 | Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. | J Am Coll Cardiol | 2005 | https://conductscience.org/library/papers/15893169 | PubMed |
| 18 | 24,433,519 | Use of myocardial matrix in a chitosan-based full-thickness heart patch. | Tissue Eng Part A | 2014 | https://conductscience.org/library/papers/24433519 | PubMed |
| 19 | 21,035,179 | Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. | Biomaterials | 2011 | https://conductscience.org/library/papers/21035179 | PubMed |
| 20 | 72,976 | Antithrombotic properties of vascular endothelium. | Lancet | 1977 | https://conductscience.org/library/papers/72976 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,069,858 | Application of biomaterials in vascularization of cardiac organoids. | iScience | 2025 | https://conductscience.org/library/papers/41069858 | PubMed |
| 39,513,306 | Stimuli-responsive Nano/Biomaterials for Smart Drug Delivery in Cardiovascular Diseases: Promises, Challenges and Outlooks. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39513306 | PubMed |
| 38,887,635 | Chitosan alchemy: transforming tissue engineering and wound healing. | RSC Adv | 2024 | https://conductscience.org/library/papers/38887635 | PubMed |
| 37,626,396 | Application of biomedical materials in the diagnosis and treatment of myocardial infarction. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37626396 | PubMed |
| 37,571,044 | Chitosan-Based Composites: Development and Perspective in Food Preservation and Biomedical Applications. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/37571044 | PubMed |
| 37,240,504 | Cells and Materials for Cardiac Repair and Regeneration. | J Clin Med | 2023 | https://conductscience.org/library/papers/37240504 | PubMed |
| 37,111,795 | Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111795 | PubMed |
| 37,110,959 | A Review on the Applications of Natural Biodegradable Nano Polymers in Cardiac Tissue Engineering. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/37110959 | PubMed |
| 36,986,668 | Chitosan-Based Biomaterials for Tissue Regeneration. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986668 | PubMed |
| 36,873,356 | Angiogenesis and Re-endothelialization in decellularized scaffolds: Recent advances and current challenges in tissue engineering. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/36873356 | PubMed |
| 36,144,581 | Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases. | Molecules | 2022 | https://conductscience.org/library/papers/36144581 | PubMed |
| 35,892,919 | Artificial Scaffolds in Cardiac Tissue Engineering. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35892919 | PubMed |
| 35,865,629 | Enhancing Stem Cell-Based Therapeutic Potential by Combining Various Bioengineering Technologies. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35865629 | PubMed |
| 34,940,314 | Chitosan as Functional Biomaterial for Designing Delivery Systems in Cardiac Therapies. | Gels | 2021 | https://conductscience.org/library/papers/34940314 | PubMed |
| 34,466,733 | 3D models of dilated cardiomyopathy: Shaping the chemical, physical and topographical properties of biomaterials to mimic the cardiac extracellular matrix. | Bioact Mater | 2022 | https://conductscience.org/library/papers/34466733 | PubMed |
| 32,901,369 | Otoliths-composed gelatin/sodium alginate scaffolds for bone regeneration. | Drug Deliv Transl Res | 2020 | https://conductscience.org/library/papers/32901369 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| CDH5 | 1,003 | PubTator's text mining | https://conductscience.org/library/genes/1003 | NCBI Gene |
| ELN | 2,006 | PubTator's text mining | https://conductscience.org/library/genes/2006 | NCBI Gene |
| FN1 | 2,335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| GAPDH | 2,597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| LIPC | 3,990 | PubTator's text mining | https://conductscience.org/library/genes/3990 | NCBI Gene |
| PECAM1 | 5,175 | PubTator's text mining | https://conductscience.org/library/genes/5175 | NCBI Gene |
| VWF | 7,450 | PubTator's text mining | https://conductscience.org/library/genes/7450 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32010293
GET https://conductscience.org/api/papers/v1/32010293/references?page=2